Hepatitis B Virus DNA Negativity Acts as a Favorable Prognostic Factor in Hepatocellular Carcinoma Patients

MLA

Tian-Tian Wang, et al. “Hepatitis B Virus DNA Negativity Acts as a Favorable Prognostic Factor in Hepatocellular Carcinoma Patients.” Asian Pacific Journal of Cancer Prevention, vol. 15, Dec. 2014, pp. 9635–41. EBSCOhost, https://doi.org/10.7314/apjcp.2014.15.22.9635.

APA

Tian-Tian Wang, Xiang Zhong, Yan-Fang Xing, Zhan-Hong Chen, Li Wei, Dan-Yun Ruan, Xiao-Kun Ma, Jie Chen, Qu Lin, Min Dong, Xing Li, Dong-Hao Wu, Ze-Xiao Lin, Xiang-Yuan Wu, & Jing-Yun Wen. (2014). Hepatitis B Virus DNA Negativity Acts as a Favorable Prognostic Factor in Hepatocellular Carcinoma Patients. Asian Pacific Journal of Cancer Prevention, 15, 9635–9641. https://doi.org/10.7314/apjcp.2014.15.22.9635

Chicago

Tian-Tian Wang, Xiang Zhong, Yan-Fang Xing, Zhan-Hong Chen, Li Wei, Dan-Yun Ruan, Xiao-Kun Ma, et al. 2014. “Hepatitis B Virus DNA Negativity Acts as a Favorable Prognostic Factor in Hepatocellular Carcinoma Patients.” Asian Pacific Journal of Cancer Prevention 15 (December): 9635–41. doi:10.7314/apjcp.2014.15.22.9635.